Arpan Patel
Arpan Patel has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Anjana Verma
Department of Community Medicine, Geetanjali Medical College and Hospital, Udaipur, Rajasthan, India
1 shared publication Dewesh Kumar
Department of Community Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
1 shared publicationDilshano Thaiyam
Department of Community Medicine, Geetanjali Medical College and Hospital, Udaipur, Rajasthan, India
1 shared publication- Medha Mathur
Department of Community Medicine, Geetanjali Medical College and Hospital, Udaipur, Rajasthan, India
1 shared publication - Navgeet Mathur
Geetanjali University, Geetanjali Medical College & Hospital, Udaipur, Rajasthan
1 shared publication
Latest Publications
- 16 November 2026
- Published by Wolters Kluwer Health in Preventive Medicine: Research & Reviews
Ensuring Safety and Efficacy: A Comprehensive Review of Vaccine Regulatory Bodies in India
Regulation of vaccines in India is indispensable to ensuring vaccine quality, effectiveness and safety. Regulation is carried out by organisations such as the Central Drugs Standard Control Organisation and the Indian Council of Medical Research and goes through manufacturing clearances and post-launch surveillance. This analysis contrasts India’s vaccine regulation framework with international regulation and highlights best practices, challenges and the future direction. The framework of regulation in India has made significant strides year by year, and following the clearance of the New Drugs and Clinical Trials Rules, 2019, to increase transparency in the development process. India faces the issues of confidence in vaccines among individuals, in capacity at the regulatory level and integration with international regulatory organisations. This article concludes that it is significant to remain globally competitive, address international support, reveal transparency in procedure and utilise electronic means to streamline regulation in vaccination. With inspiration, effort, application and dedication, drawing lessons from India’s regulation of vaccines, it is possible to refine it further, build up its health care and enhance public health.
- 16 November 2026
- Published by Wolters Kluwer Health in Preventive Medicine: Research & Reviews
Ensuring Safety and Efficacy: A Comprehensive Review of Vaccine Regulatory Bodies in India
Regulation of vaccines in India is indispensable to ensuring vaccine quality, effectiveness and safety. Regulation is carried out by organisations such as the Central Drugs Standard Control Organisation and the Indian Council of Medical Research and goes through manufacturing clearances and post-launch surveillance. This analysis contrasts India’s vaccine regulation framework with international regulation and highlights best practices, challenges and the future direction. The framework of regulation in India has made significant strides year by year, and following the clearance of the New Drugs and Clinical Trials Rules, 2019, to increase transparency in the development process. India faces the issues of confidence in vaccines among individuals, in capacity at the regulatory level and integration with international regulatory organisations. This article concludes that it is significant to remain globally competitive, address international support, reveal transparency in procedure and utilise electronic means to streamline regulation in vaccination. With inspiration, effort, application and dedication, drawing lessons from India’s regulation of vaccines, it is possible to refine it further, build up its health care and enhance public health.